Avricore Health (AVCRF) Acquisitions (2014 - 2025)

Avricore Health has disclosed Acquisitions across 9 years of filings, most recently posting $45232.1 for Q4 2022.

• In Q4 2022, Acquisitions fell 42.13% year-over-year to $45232.1; the TTM figure through Dec 2022 stood at $501763.5 (down 68.18% YoY), while the FY2023 annual figure was $204985.1, down 57.05% from the prior year.
• Acquisitions improved to $45232.1 in Q4 2022, from -$441164.3 in the prior quarter.
• Over the last five years, Acquisitions for AVCRF reached as high as $2.0 million in Q1 2021 and fell as low as -$476930.3 in Q2 2021.
• The 5-year median for Acquisitions is $615.94 (2019), against an average of $134500.9.
• Annual changes were most pronounced in 2020 — Acquisitions soared 677.65% — and 2022, when it tumbled 740.12%.
• A 5-year view of Acquisitions shows it stood at -$163944.4 in 2018, then jumped by 78.57% to -$35136.6 in 2019, then soared by 677.65% to $202968.0 in 2020, then tumbled by 61.49% to $78167.4 in 2021, then tumbled by 42.13% to $45232.1 in 2022.
• According to Business Quant data, Acquisitions over the past three periods registered $45232.1, -$441164.3, and -$310864.8 for Q4 2022, Q3 2022, and Q2 2022 respectively.